首页> 美国卫生研究院文献>Journal of Chemical Biology >Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines
【2h】

Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines

机译:IL-6诱导STAT3信号通路选择性抑制剂在头颈癌细胞系中的作用机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Studies indicate that elevated interleukin-6 (IL-6) levels engage IL6Rα-gp130 receptor complexes to activate signal transducer and activator of transcription 3 (STAT3) that is hyperactivated in many cancers including head and neck squamous cell carcinoma (HNSCC). Our previous HCS campaign identified several hits that selectively blocked IL-6-induced STAT3 activation. This study describes our investigation of the mechanism(s) of action of three of the four chemical series that progressed to lead activities: a triazolothiadiazine (864669), amino alcohol (856350), and an oxazole-piperazine (4248543). We demonstrated that all three blocked IL-6-induced upregulation of the cyclin D1 and Bcl-XL STAT3 target genes. None of the compounds exhibited direct binding interactions with STAT3 in surface plasmon resonance (SPR) binding assays; neither did they inhibit the recruitment and binding of a phospho-tyrosine-gp130 peptide to STAT3 in a fluorescence polarization assay. Furthermore, they exhibited little or no inhibition in a panel of 83 cancer-associated in vitro kinase profiling assays, including lack of inhibition of IL-6-induced Janus kinase (JAK 1, 2, and 3) activation. Further, 864669 and 4248543 selectively inhibited IL-6-induced STAT3 activation but not that induced by oncostatin M (OSM). The compounds 864669 and 4248543 abrogated IL-6-induced phosphorylation of the gp130 signaling subunit (phospho-gp130Y905) of the IL-6-receptor complex in HNSCC cell lines which generate docking sites for the SH2 domains of STAT3. Our data indicate that 864669 and 4248543 block IL-6-induced STAT activation by interfering with the recruitment, assembly, or activation of the hexamer-activated IL-6/IL-6Rα/gp130 signaling complex that occurs after IL-6 binding to IL-6Rα subunits.Electronic supplementary materialThe online version of this article (doi:10.1007/s12154-017-0169-9) contains supplementary material, which is available to authorized users.
机译:研究表明,升高的白介素6(IL-6)水平与IL6Rα-gp130受体复合物结合,从而激活信号转导子和转录激活因子3(STAT3),而在许多癌症中,包括头颈鳞状细胞癌(HNSCC),这种转录因子被高度激活。我们之前的HCS活动确定了几处可选择性阻断IL-6诱导的STAT3激活的命中。这项研究描述了我们对导致领先活动的四个化学系列中三个的作用机理的研究:三唑并噻二嗪(864669),氨基醇(856350)和恶唑-哌嗪(4248543)。我们证明了所有三个阻止细胞周期蛋白D1和Bcl-XL STAT3目标基因的IL-6诱导的上调。在表面等离振子共振(SPR)结合试验中,没有一种化合物显示出与STAT3的直接结合相互作用。在荧光偏振测定中,它们均未抑制磷酸酪氨酸-gp130肽与STAT3的募集和结合。此外,它们在83种与癌症相关的体外激酶分析试验中几乎没有或没有抑制作用,包括缺乏对IL-6诱导的Janus激酶(JAK 1、2和3)活化的抑制作用。此外,864669和4248543选择性抑制IL-6诱导的STAT3激活,而不抑制制瘤素M(OSM)诱导的激活。在HNSCC细胞系中,化合物864669和4248543消除了IL-6诱导的IL-6受体复合物gp130信号亚基(phospho-gp130Y905)的磷酸化,该磷酸化产生STAT3 SH2域的停靠位点。我们的数据表明864669和4248543通过干扰IL-6与IL结合后发生的六聚体激活的IL-6 /IL-6Rα/ gp130信号复合物的募集,组装或激活来阻断IL-6诱导的STAT激活。 -6Rα亚基。电子补充材料本文的在线版本(doi:10.1007 / s12154-017-0169-9)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号